p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab

Mounting evidence supports the role of p53 in metabolic processes involved in breast carcinogenesis. We investigated whether p53 status affects the association of pre-treatment fasting glucose with treatment outcomes in 106 non diabetic, HER2 positive breast cancer patients treated with trastuzumab....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Vici, Patrizia, Sperati, Francesca, Maugeri-Saccà, Marcello, Melucci, Elisa, Benedetto, Anna Di, Lauro, Luigi Di, Pizzuti, Laura, Sergi, Domenico, Terrenato, Irene, Esposito, Luca, Iannuzzi, Carmelina Antonella, Pasquale, Raffaella, Botti, Claudio, Fuhrman, Barbara, Giordano, Antonio, Mottolese, Marcella, Barba, Maddalena
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2014
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4279380/
https://ncbi.nlm.nih.gov/pubmed/25071015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky